Investor
RA Capital Management
2$3.8bn$2.3bn0
Startups backed by RA Capital Management that were acquired: 2 exits so far, with the buyer, the price where disclosed and every source.
Photo: Chlaborewan / Wikimedia Commons, CC BY-SA 3.0Eli Lilly agrees to buy shingles vaccine developer Curevo for up to $1.5 billion
In a Phase 2 trial against the current standard of care, Curevo's amezosvatein matched the immune response while cutting side effects such as fatigue, chills and injection-site pain by more than half.
$1.5bnn/aSeries BCorporate
Latest in RA Capital ManagementNew York · Healthtech & bioEli Lilly agrees to buy Ajax Therapeutics for up to $2.3 billion
All RA Capital Management exitsOpen tracker →
Eli Lilly → Curevo$1.5bn$1bn+Eli Lilly → Ajax Therapeutics$2.3bn$1bn+